Form 13-F position report

HUMACYTE INC

Reported by CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM

Company profile Manager portfolio Source filing
HUMA CUSIP 44486Q103 Manager CIK 0001081019
Latest reported change

Reported 9,543 shares, up 1,697 (21.6%) from the prior quarter.

Reported value -32.9%; share count 21.6% vs. the prior quarter.

Added
% of reported 13F value < 0.01% This manager · Q4 2025
Shares 9,543 Quarter-end amount reported
Reported value $9,166 Fair value at quarter end
Consecutive quarters held 17 Through Q4 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Manager history

Quarterly position history

How this manager's reported quarter-end position changed over time.

18 quarters
Quarter Activity Shares Change % of reported 13F Reported value Filed
Q1 2026 Reduced 0 -9,543 (-100.0%) 0 $0 2026-05-18
Q4 2025 Added 9,543 +1,697 (21.6%) < 0.01% $9,166 2026-02-17
Q3 2025 Added 7,846 +26 (0.3%) < 0.01% $13,652 2025-11-14
Q2 2025 Reduced 7,820 -73,988 (-90.4%) < 0.01% $16,344 2025-08-14
Q1 2025 Unchanged 81,808 0 (0.0%) < 0.01% $139,483 2025-05-15
Q4 2024 Added 81,808 +2,668 (3.4%) < 0.01% $413,130 2025-02-14
Q3 2024 Added 79,140 +72,771 (1142.6%) < 0.01% $430,522 2024-11-14
Q2 2024 Added 6,369 +211 (3.4%) < 0.01% $30,571 2024-08-14
Q1 2024 Reduced 6,158 -3,922 (-38.9%) < 0.01% $19,151 2024-05-16
Q4 2023 Reduced 10,080 -3,433 (-25.4%) < 0.01% $28,627 2024-02-13
Q3 2023 Reduced 13,513 -6,858 (-33.7%) < 0.01% $39,593 2023-11-14
Q2 2023 Reduced 20,371 -1,484 (-6.8%) < 0.01% $58,261 2023-08-21
Q1 2023 Reduced 21,855 -51,568 (-70.2%) < 0.01% $67,532 2023-05-09
Q4 2022 Added 73,423 +17,711 (31.8%) < 0.01% $154,923 2023-02-14
Q3 2022 Added 55,712 +417 (0.8%) < 0.01% $182,000 2022-11-21
Q2 2022 Added 55,295 +4,297 (8.4%) < 0.01% $177,000 2022-08-15
Q1 2022 Added 50,998 +7,219 (16.5%) < 0.01% $360,000 2022-05-16
Q4 2021 New 43,779 +43,779 (0.0%) < 0.01% $317,000 2022-02-15
Institutional context

Who else reported the position

163 managers reported HUMACYTE INC for Q4 2025.

Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 11,345,119 +1,443,324 < 0.01% $10,896,986 6 qtrs
VANGUARD GROUP INC Added 8,416,971 +896,916 < 0.01% $8,088,709 18 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 3,720,436 +624,220 < 0.01% $3,573,953 18 qtrs
UBS Group AG Added 2,978,610 +976,275 < 0.01% $2,862,445 18 qtrs
STATE STREET CORPORATION Added 2,837,276 +429,233 < 0.01% $2,725,204 17 qtrs
MILLENNIUM MANAGEMENT LLC Added 2,631,990 +1,485,152 < 0.01% $2,528,026 16 qtrs
MORGAN STANLEY Added 2,505,428 +408,675 < 0.01% $2,406,465 18 qtrs
Woodline Partners LP Unchanged 2,002,073 0 < 0.01% $1,922,991 6 qtrs
CITADEL ADVISORS LLC Added 1,566,431 +673,479 < 0.01% $1,504,557 17 qtrs
TWO SIGMA INVESTMENTS LP Added 1,491,467 +124,883 < 0.01% $1,432,554 10 qtrs
A free account expands this comparison to 25 managers. Create free account
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2025
Filed
February 17, 2026
Filing type
13F-HR
Position type
COMMON STOCK

Voting authority reported

Sole
9,543
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.